Catalyst Wire Dossier Catalyst Wire Dossier

H5N1 influenza vaccine (adjuvanted formulation 1)

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H5N1 influenza vaccine (adjuvanted formulation 1), covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults [Phase 2]

See pricing